CD274 and neoplasm: The use of RT in combination with ICI allows for potential synergistic enhancement of the cytotoxic effects of PD-L1 inhibitors through increasing PD-L1 expression and enhancing PD-L1 induction, thereby minimizing the tumor’s immunosuppressive effects.